Article Information
History
- September 17, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Justine W. Debelius1,2,*,
- Lars Engstrand1,
- Andreas Matussek3,4,5,
- Nele Brusselaers1,6,7,
- James T. Morton8,
- Margaretha Stenmarker9,10 and
- Renate S. Olsen1,9,11,*
- 1Centre for Translational Microbiome Research, Department of Microbiology, Tumor, and Cell biology. Karolinska Institutet, Solna, Sweden
- 2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health. Baltimore, MD, USA
- 3Laboratory Medicine, Jönköping Region County, Department of Clinical and Experimental Medicine, Linköping University, Jönköping, Sweden
- 4Division of Laboratory Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 5Department of Microbiology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway
- 6Global Health Institute, Antwerp University, Antwerp, Belgium
- 7Department of Head and Skin, Ghent University, Ghent, Belgium
- 8Biostatistics & Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA
- 9Futurum/Department of Pediatrics, Region Jönköping County, and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
- 10The Institute of Clinical Sciences, Department of Paediatrics, the Sahlgrenska Academy at the University of Gothenburg, Sweden
- 11Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway
- ↵*Corresponding Authors: Renate Slind Olsen, e-mail:resols{at}ous-hf.no; Justine Debelius email: justine.debelius{at}jhu.edu
Posted September 17, 2022.
The local tumor microbiome is associated with survival in late-stage colorectal cancer patients
